452 related articles for article (PubMed ID: 27449687)
1. Unmet informational and supportive care needs of patients following cystectomy for bladder cancer based on age, sex, and treatment choices.
Mohamed NE; Pisipati S; Lee CT; Goltz HH; Latini DM; Gilbert FS; Wittmann D; Knauer CJ; Mehrazin R; Sfakianos JP; McWilliams GW; Quale DZ; Hall SJ
Urol Oncol; 2016 Dec; 34(12):531.e7-531.e14. PubMed ID: 27449687
[TBL] [Abstract][Full Text] [Related]
2. Muscle invasive bladder cancer: examining survivor burden and unmet needs.
Mohamed NE; Chaoprang Herrera P; Hudson S; Revenson TA; Lee CT; Quale DZ; Zarcadoolas C; Hall SJ; Diefenbach MA
J Urol; 2014 Jan; 191(1):48-53. PubMed ID: 23911603
[TBL] [Abstract][Full Text] [Related]
3. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
4. Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder.
Dutta SC; Chang SC; Coffey CS; Smith JA; Jack G; Cookson MS
J Urol; 2002 Jul; 168(1):164-7. PubMed ID: 12050514
[TBL] [Abstract][Full Text] [Related]
5. Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
Brant A; Kates M; Chappidi MR; Patel HD; Sopko NA; Netto GJ; Baras AS; Hahn NM; Pierorazio PM; Bivalacqua TJ
Urol Oncol; 2017 Jan; 35(1):34.e17-34.e25. PubMed ID: 27639777
[TBL] [Abstract][Full Text] [Related]
6. Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy.
Siddiqui KM; Izawa JI
World J Urol; 2016 Jan; 34(1):19-24. PubMed ID: 26475274
[TBL] [Abstract][Full Text] [Related]
7. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer.
Scher HI
J Urol; 1994 Aug; 152(2 Pt 1):574-5. PubMed ID: 8015114
[No Abstract] [Full Text] [Related]
8. Unconventional Bladder Preservation: Factors Predicting Failure to Receive Definitive Surgery following Chemotherapy for Nonmetastatic Muscle Invasive Bladder Cancer in the National Cancer Database.
Kapadia AA; Martinez Acevedo A; Liu JJ; Garzotto M; Conlin M; Amling C; Kopp RP
J Urol; 2018 Sep; 200(3):535-540. PubMed ID: 29551404
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment of octogenarian neoplastic patients: bladder cancers].
Destefanis P; Bisconti A; Lasaponara F; Fontana D
Urologia; 2010; 77 Suppl 17():32-7. PubMed ID: 21308672
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
11. Quality-of-life outcomes and unmet needs between ileal conduit and orthotopic ileal neobladder after radical cystectomy in a Chinese population: a 2-to-1 matched-pair analysis.
Huang Y; Pan X; Zhou Q; Huang H; Li L; Cui X; Wang G; Jizhong R; Yin L; Xu D; Hong Y
BMC Urol; 2015 Nov; 15():117. PubMed ID: 26610351
[TBL] [Abstract][Full Text] [Related]
12. [Orthotopic ileal neobladders in men and women: techniques and comparison].
Rocco F; Scardino E; Carmignani L; Frea B; Strada G; Kocjancic E; Franchini V; De Cobelli O; Panizzutti M
Arch Ital Urol Androl; 1996 Dec; 68(5):293-8. PubMed ID: 9026229
[TBL] [Abstract][Full Text] [Related]
13. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
[TBL] [Abstract][Full Text] [Related]
14. Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.
Chung J; Kulkarni GS; Morash R; Matthew A; Papadakos J; Breau RH; Guttman D; Bender J; Jones JM
Support Care Cancer; 2019 Oct; 27(10):3877-3885. PubMed ID: 30767131
[TBL] [Abstract][Full Text] [Related]
15. Robot-assisted radical cystectomy with intracorporeal urinary diversion in patients with transitional cell carcinoma of the bladder.
Jonsson MN; Adding LC; Hosseini A; Schumacher MC; Volz D; Nilsson A; Carlsson S; Wiklund NP
Eur Urol; 2011 Nov; 60(5):1066-73. PubMed ID: 21852033
[TBL] [Abstract][Full Text] [Related]
16. Socioeconomic status is associated with urinary diversion utilization after radical cystectomy for bladder cancer.
Maurice MJ; Kim SP; Abouassaly R
Int Urol Nephrol; 2017 Jan; 49(1):77-82. PubMed ID: 27696214
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy for urothelial cancer of the bladder--update 2012].
Niegisch G; Lorch A; Albers P
Aktuelle Urol; 2012 Dec; 43(6):412-9. PubMed ID: 23196781
[TBL] [Abstract][Full Text] [Related]
18. Management of high-risk non-muscle invasive bladder cancer.
Brausi M; Olaru V
Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
[TBL] [Abstract][Full Text] [Related]
19. Decision Regret Related to Urinary Diversion Choice among Patients Treated with Cystectomy.
Check DK; Leo MC; Banegas MP; Bulkley JE; Danforth KN; Gilbert SM; Kwan ML; Rosetti MO; McMullen CK
J Urol; 2020 Jan; 203(1):159-163. PubMed ID: 31441673
[TBL] [Abstract][Full Text] [Related]
20. De novo muscle invasive bladder cancer: is there a change in trend?
Vaidya A; Soloway MS; Hawke C; Tiguert R; Civantos F
J Urol; 2001 Jan; 165(1):47-50; discussion 50. PubMed ID: 11125361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
